Novartis Shanghai R&D Center To Focus On Diseases Prevalent In China
This article was originally published in The Pink Sheet Daily
Executive Summary
Establishment of the R&D site reflects Novartis’ commitment to the region, according to the drug maker.
You may also be interested in...
GSK Jumps Into Growing China R&D Space
GlaxoSmithKline has joined a growing list of big pharma companies expanding in China, launching a research and development center based in Shanghai, the company announced May 24
GSK Jumps Into Growing China R&D Space
Shanghai-based center will focus on Alzheimer’s, multiple sclerosis and Parkinson’s.
GSK Jumps Into Growing China R&D Space
Shanghai-based center will focus on Alzheimer’s, multiple sclerosis and Parkinson’s.